Immunomodulator tuftsin increases the susceptibility of Cryptococcus neoformans to liposomal amphotericin B in immunocompetent BALB/c mice

Journal of Drug Targeting

Volumn 13, Issue 7, 2005, Pages 423-429

  Khan, Masood A ^a,b   Owais, Mohammad ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Amphotericin B; Cryptococcus neoformans; Liposomes; Tuftsin

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; IMMUNOMODULATING AGENT; TUFTSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE SEVERITY; FEMALE; IMMUNOCOMPETENCE; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG THERAPY, COMBINATION; FEMALE; IMMUNOCOMPETENCE; IMMUNOLOGIC FACTORS; LIPOSOMES; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; TUFTSIN;

EID: 30644464351     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860500403222     Document Type: Article

References (28)

1. Agarwal, A and Kandpal, H and Gupta, HP and Singh, NB and Gupta, CM. (1994) Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice Antimicrob Agents Chemother, 38, pp. 588 - 593.
2. Agrawal, AK and Agrawal, A and Pal, A and Guru, PY and Gupta, CM. (2002) Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters J Drug Target, 10, pp. 41 - 45.
3. Bauman, SK and Huffnagle, GB and Murphy, JW. (2003) Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response Infect Immun, 71, pp. 68 - 74.
4. Canuto, MM and Rodero, GF. (2002) Antifungal drug resistance to azoles and polyenes Lancet Infectious Diseases, 2, pp. 550 - 563.
5. Chen, WC and Chou, DL and Feingold, DS. (1978) Dissociation between ion permeability and the lethal action of polyene antibiotics on C. albicans Antimicrob Agents Chemother, 13, pp. 914 - 917.
6. Cillari, E and Arcoleo, F and Dieli, M and D'Agostino, R and Gromo, G and Leoni, F and Milano, S. (1994) The macrophage activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill leishmania parasites in vitro Infect Immun, 62, pp. 2649 - 2652.
7. Constantopoulos, A and Najjar, VA. (1972) Tuftsin, a natural and general phagocytosis stimulating peptide-affecting macrophages and polymorphonuclear granulocytes Cytobios, 6, pp. 97 - 101.
8. Dupont, B. (2002) Overview of the lipid formulations of amphotericin B J Antimicrob Chemother, 49, pp. 31 - 36.
9. Fleuridor, R and Lees, A and Pirofski, L. (2001) A cryptococcal capsular polysachharide mimotope prologs the survival of mice with Cryptococcus neoformans infection J Immunol, 166, pp. 1087 - 1096.
10. Fridkin, M and Tsubery, H and Tzehoval, E and Vonsover, A and Biondi, L and Filira, F and Rocchi, R. (2005) Tuftsin-AZT conjugate: Potential macrophage targeting for AIDS therapy J Pept Sci, 11, pp. 37 - 44.
11. Gupta, CM and Puri, A and Jain, RK and Bali, A and Anand, N. (1986) Protection of mice against Plasmodium berghei infection by a tuftsin derivative FEBS Lett, 205, pp. 351 - 354.
12. Khan, MA and Faisal, SM and Haque, W and Owais, M. (2002) Immunomodulator tuftsin augments antifungal activity of Amp B against experimental murine Candidiasis J Drug Target, 10, pp. 185 - 192.
13. Khan, MA and Faisal, SM and Nasti, HT and Khan, S and Haq, W and Shehbaz, A and Owais, M. (2003) Use of tuftsin bearing nystatin liposomes against an isolate of C. albicans showing less in vivo susceptibility to amphotericin B J Drug Target, 11, pp. 93 - 99.
14. Khan, MA and Nasti, TH and Khanam, S and Mallick, AI and Shehbaz, A and Wajahul, H and Mohammad, O. (2004) Coadministration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice FEMS Immunol Med Microbiol, 41, pp. 249 - 258.
15. Krcmery, V and Krupova, I and Denning, DW. (1999) Invasive yeast infections other than Candida spp. in acute leukaemia J Hosp Infect, 41, pp. 181 - 194.
16. Kullberg, BJ. (1997) Trends in immunotherapy of fungal infections Eur J Clin Microbiol Infect Dis, 16, pp. 51 - 55.
17. Mitchell, TG and Perfect, JR. (1995) Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans Clin Microbiol Rev, 8, pp. 515 - 548.
18. Murphy, JW and Friedman, H and Bendinelli, M.(1993) Fungal infections and immune responses. New York: Plenum Press.
19. National Committee for Clinical Laboratory Standards.(1997) Reference Method for broth dilution antifungal susceptibility testing for yeasts. Villanova, PA: National Committee for Clinical laboratory standards. Approved standard M 27-A
20. Owais, M and Krishnakumar, B and Jain, RK and Bachhawat, BK and Gupta, CM. (1993) Tuftsin bearing liposomes as drug vehicles in the treatment of experimental aspergillosis FEBS Lett, 326, pp. 56 - 58.
21. Roilides, E and Dignani, MC and Anaissie, EJ and Rex, JH. (1998) The role of immunoreconstitution in the management of refractory opportunistic fungal infections Med Mycol, 36, pp. 12 - 25.
22. Siemion, IZ and Kluczyk, A. (1999) Tuftsin: On the 30-year anniversary of Victor Najjar's discovery Peptides, 20, pp. 645 - 674.
23. Singhal, A and Bali, A and Jain, RK and Gupta, CM. (1984) Specific interactions of liposomes with PMN leukocytes upon incorporating tuftsin in their bilayers FEBS Lett, 178, pp. 109 - 113.
24. Singleton, WS and Gray, MS and Brown, ML. (1965) A method for adsorbent fractionation of cottonseed oil for experimental intravenous fat emulsions J Am Oil Chem Soc, 42, pp. 53 - 56.
25. Stevens, DA. (1998) Combination immunotherapy and antifungal chemotherapy Clin Infect Dis, 26, pp. 1266 - 1269.
26. Trevisani, F and Castelli, E and Foschi, FG and Parazza, M and Loggi, E and Bertelli, M and Melotti, C and Domenicali, M and Zoli, G and Bernardi, M. (2002) Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome Gut, 50, pp. 707 - 712.
27. Vilchez, RA and Fung, J and Kusne, S. (2002) Cryptococcosis in organ transplant recipients: An overview Am J Transplant, 2, pp. 575 - 580.
28. Yamaguchi, H and Abe, S and Tokuda, Y. (1993) Immunomodulating activity of antifungal drugs Ann NY Acad Sci, 685, pp. 447 - 457.